Detalhe da pesquisa
1.
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
Proc Natl Acad Sci U S A
; 119(15): e2120787119, 2022 04 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35385357
2.
ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression.
Haematologica
; 2024 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38356460
3.
Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma.
BMC Cancer
; 24(1): 406, 2024 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38565996
4.
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).
Proc Natl Acad Sci U S A
; 118(6)2021 02 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33495363
5.
Real-World Experience of PD-1 Inhibitors for Relapsed and Refractory Hodgkin Lymphoma: A Multicenter Retrospective Analysis of Patients in China.
Acta Haematol
; 146(4): 307-315, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37023729
6.
Ectopic expression of a combination of 5 genes detects high risk forms of T-cell acute lymphoblastic leukemia.
BMC Genomics
; 23(1): 467, 2022 Jun 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35751016
7.
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma.
Proc Natl Acad Sci U S A
; 116(19): 9543-9551, 2019 05 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30988175
8.
Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.
Proc Natl Acad Sci U S A
; 115(2): 373-378, 2018 01 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29279377
9.
Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement.
Proc Natl Acad Sci U S A
; 114(20): 5237-5242, 2017 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-28461508
10.
Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
BMC Cancer
; 19(1): 1072, 2019 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31703632
11.
Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia.
J Cell Mol Med
; 22(3): 1614-1626, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29266867
12.
Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia.
Eur J Haematol
; 100(4): 344-350, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29266395
13.
A novel KMT2A-USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia.
Br J Haematol
; 192(1): e32-e36, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33216970
14.
A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
Blood
; 124(10): 1645-54, 2014 Sep 04.
Artigo
Inglês
| MEDLINE | ID: mdl-25006128
15.
The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
Acta Haematol
; 135(4): 217-23, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26967450
16.
Preferential eradication of acute myelogenous leukemia stem cells by fenretinide.
Proc Natl Acad Sci U S A
; 110(14): 5606-11, 2013 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-23513221
17.
Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China.
Proc Natl Acad Sci U S A
; 110(42): 17017-22, 2013 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24082129
18.
C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.
Proc Natl Acad Sci U S A
; 108(6): 2450-5, 2011 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-21262832
19.
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma.
Nat Commun
; 15(1): 360, 2024 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38191582
20.
Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China.
J Immunother Cancer
; 12(5)2024 May 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38802271